Cite
HARVARD Citation
Rajagopalan, K. et al. (2013). Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data. Journal of medical economics. pp. 951-961. [Online].